Literature DB >> 24139185

AMP v Myriad: the Supreme Court gives a win to personalized medicine.

Roger D Klein1.   

Abstract

The guest editorial provides perspective to the decision by the Supreme Court of the United States in the case of Association for Molecular Pathology v Myriad Genetics, Inc.
Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24139185     DOI: 10.1016/j.jmoldx.2013.09.002

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  2 in total

1.  Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent.

Authors:  Li Jiang
Journal:  Sci Eng Ethics       Date:  2018-03-12       Impact factor: 3.525

2.  A Balanced Look at the Implications of Genomic (and Other "Omics") Testing for Disease Diagnosis and Clinical Care.

Authors:  Scott D Boyd; Stephen J Galli; Iris Schrijver; James L Zehnder; Euan A Ashley; Jason D Merker
Journal:  Genes (Basel)       Date:  2014-09-01       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.